Skip to main content

Table 1 Overview on the 12 known imprinting disorders and the ratio of MLID in specific molecular subgroups

From: Trans-acting genetic variants causing multilocus imprinting disturbance (MLID): common mechanisms and consequences

Imprinting disorder (abbreviation)

OMIM

Chromosome

Primary epimutation (frequency)a

MLID frequency observed for the respective epimutationb

Transient neonatal diabetes mellitus (TNDM)

601410

Chr 6q24

PLAGL1:alt-TSS-DMR LOM (30%)

30%

Silver–Russell syndrome (SRS)

180860

Chr 11p15

H19/IGF2:IG-DMR LOM (30–60%)

7–10%

Birk–Barel syndrome (BIBARS)

612292

Chr 8q24.3

Epimutation not yet reported

Beckwith–Wiedemann syndrome (BWS)

130650

Chr 11p15

KCNQ1OT1:TSS-DMR LOM (50%)

25%

H19/IGF2:IG-DMR GOM (5–10%)

Kagami–Ogata syndrome (KOS14)

608149

Chr 14q32

MEG3/DLK1:IG-DMR GOM (15%)

Temple syndrome (TS14)

616222

Chr 14q32

MEG3/DLK1:IG-DMR LOM (18.8%)

Unclearc

Prader–Willi syndrome (PWS)

176270

Chr 15q11–q13

SNURF:TSS-DMR GOM (1%)

1 case

Angelman syndrome (AS)

105830

Chr 15q11–q13

SNURF:TSS-DMR LOM (2–3%)

Central precocious puberty 2 (CPPB2)

615346

Chr 15q11.2

Epimutation not yet reported

Schaaf–Yang syndrome (SYS)

615547

Chr 15q11.2

Epimutation not yet reported

Pseudohypoparathyroidism 1B (PHP1B)

603233

Chr 20q13

Maternal GNAS DMRs LOM with paternal GNAS DMR GOM (42.5%)

12.5%

Mulchandani–Bhoj–Conlin syndrome (MBCS)

617352

Chr 20

Epimutation not yet reported

  1. aFrequency of the epimutation among other genetic/epigenetic changes causative for a given disorder. LOM, loss of methylation; GOM, gain of methylation
  2. bReviewed by [4]
  3. cSome TS14 patients have been reported with aberrant methylation at imprinted loci, but in these patients clinically relevant CpGs were not affected with the exception of those in 14q32 [18, 38]